Mental Health DisorderI-CARENCT06233747
Improving Care, Accelerating Recovery and Education
A study testing Improving Care, Accelerating Recovery & Education (ICARE) in people with Mental Health Disorder and Suicide Attempt, run by Dartmouth-Hitchcock Medical Center at 2 sites in United States.
Trial summary
The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program? Does the I-CARE… Read more about this study
- Who is it for?
- Ages 12 to 17 years
- Conditions the study is for
- Mental Health Disorder, Suicide Attempt, Suicidal Ideation
- What is being tested?
- Improving Care, Accelerating Recovery & Education (ICARE)
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 89 participants
- Where
- 2 sitesUnited States
- Study dates
- 29 Feb 2024to 31 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Adolescents aged 12-17 years
- Ability to speak and complete surveys in English
- Presented to ED with suicidal ideation or attempt
- Awaiting psychiatric disposition
- Receiving one-on-one safety supervision
- Medically stable
Who cannot join
- Cognitive or developmental delays that preclude program participation based on clinical team assessment
- Diagnosis of psychosis
- Primary reason for hospitalization or ED visit is an eating disorder
- Parent/guardian not able to provide consent in English
- Admission or transfer for psychiatric care anticipated on the first day of potential enrollment
- Clinical team concern for patient or staff safety based upon active behavioral concerns
- In child protective custody/ward of the state
Trial locations and contacts
2 sites in 1 country.
United States2 sites
University of Vermont Medical Center
Burlington, Vermont, 05401
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
About this study
Official title: I-CARE: The Effectiveness of a Modular Digital Intervention to Reduce Suicidal Ideation and Emotional Distress During Pediatric Psychiatric Boarding
The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are:
- Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program?
- Does the I-CARE program lower patients' emotional distress, thoughts about suicide or suicide attempts?
Patients will complete as many of the 7 I-CARE videos as possible during their stay at the medical hospital and fill out online surveys. There are workbook activities that go with each I-CARE video. A hospital staff member will help the patient do the videos and workbook activities.
Read the detailed description
The COVID-19 pandemic has contributed to a dramatic and unprecedented rise in pediatric mental health conditions, with rates of depression and anxiety doubling from pre-pandemic estimates. These increases exacerbate decades-long trends of increasing youth suicidality. Suicide is the second leading cause of death among adolescents; from 2007 to 2017 suicide deaths tripled in youth 10 to 14 years. Emergency departments (EDs) at acute care hospitals increasingly serve as portals of care for youth with suicidal ideation or attempt. When these youth are deemed to require psychiatric hospitalization, the demand for beds often exceeds supply, leading to psychiatric boarding. To address this gap, a multidisciplinary team including pediatricians, psychologists and patient partners developed a modular digital intervention and associated training materials to deliver evidence-based psychosocial skills to youth during boarding. This program, entitled I-CARE (Improving Care, Accelerating Recovery \& Education), consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants who provide 1-on-1 safety supervision during boarding. Given that 1-on-1 safety supervision is the current standard of care at most hospitals, I-CARE requires minimal additional resources beyond those already available in these settings. The psychosocial skills included in I-CARE are grounded in cognitive behavioral therapy and were prioritized through a rigorous Delphi process evaluating their importance and feasibility to deliver during psychiatric boarding.
Aim 1:
Adapt and refine I-CARE training and implementation materials, taking into account variation in hospital resources and boarding locations while maintaining implementation fidelity.
Aim 2:
Using an open pilot/case series design, assess I-CARE feasibility and engagement of target mechanisms from the perspectives of youth, caregivers, and clinicians using a mixed-methods approach.
Aim 3:
Determine the preliminary effectiveness of I-CARE to reduce emotional distress and suicidal risk compared to usual care in youth experiencing boarding for suicidal ideation or attempt, and assess the effects of I-CARE on readiness for change, suicide-related coping, hope, and mental health treatment engagement.
- Being tested
- Improving Care, Accelerating Recovery & Education (ICARE)
- Keywords
- children, adolescents, emergency department, psychosocial skills, mental health boarding
- Medical subject headings
- Mental Disorders, Suicide, Attempted, Suicidal Ideation, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Improving Care, Accelerating Recovery & Education (ICARE)Behavioural
I-CARE is a brief, digital intervention designed for adolescents who are boarding in a medical hospital awaiting transfer to a psychiatric inpatient unit. It consists of 7 tablet-based animated video modules and workbook exercises, facilitated by licensed nursing assistants or other non-specialist clinicians who provide one-on-one safety supervision during boarding. All modules are grounded in evidence-based practices, such as cognitive-behavioral therapy and dialectical behavior therapy. Given that one-on-one safety supervision is the current standard of care during boarding, I-CARE requires minimal additional resources beyond those already available in acute care hospitals and builds on well established research demonstrating the effectiveness of task-sharing, the redistribution of tasks within the workforce, to address the shortage of mental health professionals.
| Study group | Role | What they receive |
|---|---|---|
| I-CARE | Experimental | I-CARE (Improving Care, Accelerating Recovery \& Education) is a quality improvement program designed to deliver evidence-based psychosocial skills to adolescents during mental health boarding. The program consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants/behavioral health technicians/safety attendants who provide one-on-one safety supervision during boarding. I-CARE will be offered to all eligible adolescents who are boarding and only those who agree to participate in a program evaluation will be involved in the research component. Receives: Behavioral: Improving Care, Accelerating Recovery & Education (ICARE) |
| Usual Care | No intervention | These hospitals currently offer basic safety supervision and medical monitoring for adolescents during mental health boarding. This is the "usual care" condition. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Depression, Anxiety, and Stress Scale, Youth (DASS-Y) Total Score
The DASS-Y is a 21-item, youth-oriented validated measure that generates an aggregate assessment of emotional distress and sub-measures of depression, anxiety, and stress. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
Change in Concise Health Risk Tracking, Self-Report (CHRT-SR-9) Total Score
The Concise Health Risk Tracking, Self-Report (CHRT-SR-9) is a 9-item survey that assesses suicidal thoughts and behaviors in the past week, with response options ranging 0-4. Total scores range 0-36, with higher scores indicating more severe suicidality. The CHRT-SR-9 includes 4 sub-measures: Pessimism, Helplessness, Despair \& Suicidal Thoughts.
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) postdischarge
Change in Harkavy-Asnis Suicide Scale (HASS), Suicide Attempt Module (HASS-SA)
The HASS consists of 21 self-report items that cover the range of suicidal ideation and attempts, including both passive and active ideation. Responses on each item range 0-4; total scores range 0-84, with higher scores indicating more severe suicidality. The study will use only the HASS-SA, the 2 questions that inquire about suicide attempts.
Measured: 30 days (T3), 3 months (T4), and 6 months (T5) postdischarge
Secondary outcomes (8)
DASS-Y Depression Subscale
The DASS-Y Depression Subscale is a 7-item sub-measure of the 21-item DASS-Y. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
DASS-Y Anxiety Subscale
The DASS-Y Anxiety Subscale is a 7-item sub-measure of the 21-item DASS-Y. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
DASS-Y Stress Subscale
The DASS-Y Stress Subscale is a 7-item sub-measure of the 21-item DASS-Y. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Pessimism Subscale
The CHRT-SR-9 Pessimism Subscale is a 2-item subscale of the CHRT-SR-9. It consists of the items "I feel as if things are never going to get better" and "I have no future," with response options ranging 0-4.
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Helplessness Subscale
The CHRT-SR-9 Helplessness Subscale is a 2-item subscale of the CHRT-SR-9. It consists of the items "It seems as if I can do nothing right" and "Everything I do turns out wrong," with response options ranging 0-4.
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Despair Subscale
The CHRT-SR-9 Despair Subscale is a 2-item subscale of the CHRT-SR-9. It consists of the items "I Feel that there is no reason to live" and "I Wish I could just go to sleep and not wake up," with response options ranging 0-4.
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Suicidal Thoughts Subscale
The CHRT-SR-9 Suicidal Thoughts Subscale is a 3-item subscale of the CHRT-SR-9. It consists of the items "I Have been having thoughts of killing myself," "I Have thoughts about how I might kill myself" and "I Have a plan to kill myself," with response options ranging 0-4.
Measured: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
Disposition change
This is a dichotomous variable defined as discharge to home instead of inpatient psychiatric care and will be gathered from electronic medical records.
Measured: Hospital discharge/approximately 72 hours after admission (T2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jan 2024
- Study start29 Feb 2024
- Primary completion25 Jul 2026
- Study completion31 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental Health DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a stepped wedge pilot study, in which 2 hospitals will be randomized to begin implementation of I-CARE at 2 different times within the 17-month study period. Both sites begin with an initial 3-month period of treatment-as-usual and the research team collects all outcome measures during this period, then 1 hospital will crossover to launch the I-CARE intervention and the other will launch 2 months later (continuing to provide treatment-as-usual in the interim). This may be considered a form of a parallel cluster study, in which one of the two hospitals is initially randomized to I-CARE while the other remains in the baseline/treatment-as-usual state.
- Masking
- None (open label)
- Enrolment
- 89 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH), Dartmouth College, Children's Hospital of Philadelphia, University of Vermont
- Responsible party
- Principal investigator, JoAnna K. Leyenaar, Dartmouth-Hitchcock Medical Center
- Investigators
- JoAnna K Leyenaar, MD, PhD, MPH, Principal investigator, Dartmouth Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06233747
- Sponsor's protocol ID
- STUDY02002045
- Other IDs
- RF1MH134626
- Acronym
- I-CARE
- Status last verified
- Sep 2026
- First submitted
- 12 Jan 2024
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data will be uploaded into the NIMH Data Archive (NDA). Data will be collected from approximately 109 adolescents 12-17 years of age. Measures include: 1. Depression, Anxiety, and Stress Scale - Youth version (DASS-Y) 2. Harkavy-Asnis Suicide Scale (HASS) - Suicide Attempt module 3. Concise-Health Risk Tracking-Self Report (CHRT) 4. Efficacy to Cope with Suicidal Thoughts and Urges Scale 5. The Children's Hope Scale 6. My Thoughts about Therapy Expectancy Scale 7. Cunningham Treatment Engagement Readiness to Change Scale 8. DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure for Youth 9. RCADS-25 for Youth
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- I-CARE: The Effectiveness of a Modular Digital Intervention to Reduce Suicidal Ideation and Emotional Distress During Pediatric Psychiatric Boarding
- ClinicalTrials.gov ID
- NCT06233747
- Acronym / sponsor ID
- I-CARE / STUDY02002045
- Keywords
- children, adolescents, emergency department, psychosocial skills, mental health boarding
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 89 participants (actual)
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterUniversity, hospital or other
- Collaborators
- National Institute of Mental Health (NIMH), Dartmouth College, Children's Hospital of Philadelphia, University of Vermont
- Study start
- 29 Feb 2024 (actual)
- Primary completion
- 25 Jul 2026 (actual)
- Study completion
- 31 Jul 2026 (actual)
- First posted
- 31 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are:
- Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program?
- Does the I-CARE program lower patients' emotional distress, thoughts about suicide or suicide attempts?
Patients will complete as many of the 7 I-CARE videos as possible during their stay at the medical hospital and fill out online surveys. There are workbook activities that go with each I-CARE video. A hospital staff member will help the patient do the videos and workbook activities.
Detailed description
The COVID-19 pandemic has contributed to a dramatic and unprecedented rise in pediatric mental health conditions, with rates of depression and anxiety doubling from pre-pandemic estimates. These increases exacerbate decades-long trends of increasing youth suicidality. Suicide is the second leading cause of death among adolescents; from 2007 to 2017 suicide deaths tripled in youth 10 to 14 years. Emergency departments (EDs) at acute care hospitals increasingly serve as portals of care for youth with suicidal ideation or attempt. When these youth are deemed to require psychiatric hospitalization, the demand for beds often exceeds supply, leading to psychiatric boarding. To address this gap, a multidisciplinary team including pediatricians, psychologists and patient partners developed a modular digital intervention and associated training materials to deliver evidence-based psychosocial skills to youth during boarding. This program, entitled I-CARE (Improving Care, Accelerating Recovery \& Education), consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants who provide 1-on-1 safety supervision during boarding. Given that 1-on-1 safety supervision is the current standard of care at most hospitals, I-CARE requires minimal additional resources beyond those already available in these settings. The psychosocial skills included in I-CARE are grounded in cognitive behavioral therapy and were prioritized through a rigorous Delphi process evaluating their importance and feasibility to deliver during psychiatric boarding.
Aim 1:
Adapt and refine I-CARE training and implementation materials, taking into account variation in hospital resources and boarding locations while maintaining implementation fidelity.
Aim 2:
Using an open pilot/case series design, assess I-CARE feasibility and engagement of target mechanisms from the perspectives of youth, caregivers, and clinicians using a mixed-methods approach.
Aim 3:
Determine the preliminary effectiveness of I-CARE to reduce emotional distress and suicidal risk compared to usual care in youth experiencing boarding for suicidal ideation or attempt, and assess the effects of I-CARE on readiness for change, suicide-related coping, hope, and mental health treatment engagement.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This is a stepped wedge pilot study, in which 2 hospitals will be randomized to begin implementation of I-CARE at 2 different times within the 17-month study period. Both sites begin with an initial 3-month period of treatment-as-usual and the research team collects all outcome measures during this period, then 1 hospital will crossover to launch the I-CARE intervention and the other will launch 2 months later (continuing to provide treatment-as-usual in the interim). This may be considered a form of a parallel cluster study, in which one of the two hospitals is initially randomized to I-CARE while the other remains in the baseline/treatment-as-usual state.
| Arm | Type | Receives |
|---|---|---|
| I-CARE | Experimental | Behavioral: Improving Care, Accelerating Recovery & Education (ICARE)I-CARE (Improving Care, Accelerating Recovery \& Education) is a quality improvement program designed to deliver evidence-based psychosocial skills to adolescents during mental health boarding. The program consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants/behavioral health technicians/safety attendants who provide one-on-one safety supervision during boarding. I-CARE will be offered to all eligible adolescents who are boarding and only those who agree to participate in a program evaluation will be involved in the research component. |
| Usual Care | No intervention | –These hospitals currently offer basic safety supervision and medical monitoring for adolescents during mental health boarding. This is the "usual care" condition. |
Who may qualify
- Ages
- 12 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (6 listed)
- Adolescents aged 12-17 years
- Ability to speak and complete surveys in English
- Presented to ED with suicidal ideation or attempt
- Awaiting psychiatric disposition
- Receiving one-on-one safety supervision
Key exclusion criteria (7 listed)
- Cognitive or developmental delays that preclude program participation based on clinical team assessment
- Diagnosis of psychosis
- Primary reason for hospitalization or ED visit is an eating disorder
- Parent/guardian not able to provide consent in English
- Admission or transfer for psychiatric care anticipated on the first day of potential enrollment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Improving Care, Accelerating Recovery & Education (ICARE)I-CARE is a brief, digital intervention designed for adolescents who are boarding in a medical hospital awaiting transfer to a psychiatric inpatient unit. It consists of 7 tablet-based animated video modules and workbook exercises, facilitated by licensed nursing assistants or other non-specialist clinicians who provide one-on-one safety supervision during boarding. All modules are grounded in evidence-based practices, such as cognitive-behavioral therapy and dialectical behavior therapy. Given that one-on-one safety supervision is the current standard of care during boarding, I-CARE requires minimal additional resources beyond those already available in acute care hospitals and builds on well established research demonstrating the effectiveness of task-sharing, the redistribution of tasks within the workforce, to address the shortage of mental health professionals. | Behavioural | I-CARE |
Primary outcome
Change in Depression, Anxiety, and Stress Scale, Youth (DASS-Y) Total Score
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
The DASS-Y is a 21-item, youth-oriented validated measure that generates an aggregate assessment of emotional distress and sub-measures of depression, anxiety, and stress. Each item is self-reported on a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much, or most of the time).
Change in Concise Health Risk Tracking, Self-Report (CHRT-SR-9) Total Score
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) postdischarge
The Concise Health Risk Tracking, Self-Report (CHRT-SR-9) is a 9-item survey that assesses suicidal thoughts and behaviors in the past week, with response options ranging 0-4. Total scores range 0-36, with higher scores indicating more severe suicidality. The CHRT-SR-9 includes 4 sub-measures: Pessimism, Helplessness, Despair \& Suicidal Thoughts.
Change in Harkavy-Asnis Suicide Scale (HASS), Suicide Attempt Module (HASS-SA)
Time frame: 30 days (T3), 3 months (T4), and 6 months (T5) postdischarge
The HASS consists of 21 self-report items that cover the range of suicidal ideation and attempts, including both passive and active ideation. Responses on each item range 0-4; total scores range 0-84, with higher scores indicating more severe suicidality. The study will use only the HASS-SA, the 2 questions that inquire about suicide attempts.
8 secondary outcomes
DASS-Y Depression Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
DASS-Y Anxiety Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
DASS-Y Stress Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Pessimism Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Helplessness Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Despair Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
CHRT-SR-9 Suicidal Thoughts Subscale
Time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge
Disposition change
Time frame: Hospital discharge/approximately 72 hours after admission (T2)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Individual participant dataSharing planned: Yes. Data will be uploaded into the NIMH Data Archive (NDA). Data will be collected from approximately 109 adolescents 12-17 years of age. Measures include: 1. Depression, Anxiety, and Stress Scale - Youth version (DASS-Y) 2. Harkavy-Asnis Suicide Scale (HASS) - Suicide Attempt module 3. Concise-Health Risk Tracking-Self Report (CHRT) 4. Efficacy to Cope with Suicidal Thoughts and Urges Scale 5. The Children's Hope Scale 6. My Thoughts about Therapy Expectancy Scale 7. Cunningham Treatment Engagement Readiness to Change Scale 8. DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure for Youth 9. RCADS-25 for Youth
Related trials for Mental Health Disorder
Not yet recruiting
FUS Neuromodulation for Binge Eating Disorder
Binge-Eating Disorder
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
Recruiting
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Alzheimer's Disease (AD), Frontotemporal Dementia (FTD)
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Enrolling by invitationPhase 2
Tau PET Outcomes With Anti-amyloid Immunotherapies
Cognitive Impairment, Mild, Dementia, Mild
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
JoAnna K Leyenaar, MD, PhD, MPH principal investigator
Dartmouth Health
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Improving Care, Accelerating Recovery & Education (ICARE) in people with Mental Health Disorder and Suicide Attempt, run by Dartmouth-Hitchcock Medical Center at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Depression, Anxiety, and Stress Scale, Youth (DASS-Y) Total Score (time frame: Baseline/hospital admission (T1), hospital discharge/approximately 72 hours after admission (T2), and 30 days (T3), 3 months (T4), and 6 months (T5) post-discharge). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.